The Effect of Connective Tissue Massage on Pressure Pain Threshold in Fibromyalgia
August 27, 2026 updated by: Beyza Avcı, Ankara Yildirim Beyazıt University
Investigation of the Immediate Effect of Connective Tissue Massage on Pressure Pain Threshold in Fibromyalgia
The aim of this randomized controlled study is to investigate the immediate effect of connective tissue massage (CTM) on the pressure pain threshold (PPT) in women with fibromyalgia.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
58
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Having a diagnosis of FM
- Being a woman between the ages of 18 and 65
- Being willing to participate in the study
Exclusion Criteria:
- Diagnosed additional neurological, infectious, and other inflammatory rheumatic diseases; uncontrolled endocrine and/or autoimmune diseases
- Severe psychiatric disorders
- Pregnancy or breastfeeding
- Malignancy
- Presence of acute inflammation, open wounds, or erythema in the massage areas
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
No Intervention: Control Group
|
|
|
Experimental: CTM Group
|
Single-session CTM application for the entire back
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Measurement of pressure pain threshold
Time Frame: Baseline and 20 minutes post-intervention
|
PPT will be determined using a handheld digital algometer with a 1 cm² probe.
Measurements will be taken bilaterally at three points: the trapezius, lumbar region, and pretibial area.
In the control group, the first measurement will be taken, followed by a second measurement approximately 20 minutes later.
In the CTM group, measurements will be taken before and after the CTM procedure.
|
Baseline and 20 minutes post-intervention
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
September 1, 2026
Primary Completion (Estimated)
October 1, 2026
Study Completion (Estimated)
April 1, 2027
Study Registration Dates
First Submitted
August 25, 2026
First Submitted That Met QC Criteria
August 25, 2026
First Posted (Actual)
August 27, 2026
Study Record Updates
Last Update Posted (Actual)
August 31, 2026
Last Update Submitted That Met QC Criteria
August 27, 2026
Last Verified
August 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2026/6-30
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.